
Home / All Categories / DMEPOS Modifiers / Modifier KO
Modifier KO
Single Drug Unit-Dose Formulation
Modifier KO identifies a single inhalation drug dispensed in a ready-to-use unit-dose container, supporting accurate Medicare nebulizer medication billing and claim processing.
On This Page
Related Modifiers
Modifier KP
First Drug in Combination
Modifier KQ
Additional Combination Drug
Policy Requirements Met
What Is Modifier KO?
Modifier KO is a HCPCS Level II modifier used to identify a single drug supplied in a unit-dose formulation for nebulizer treatment.
Medicare uses KO to distinguish single-drug unit-dose inhalation solutions from formulations containing multiple drugs and from concentrated inhalation medications that require dilution.
A unit-dose formulation is supplied in a vial, ampule, or similar container holding the amount typically used for one inhalation treatment. The medication must be sufficiently diluted to administer without adding a separate diluent.
When a single eligible inhalation drug is dispensed in this form, the supplier appends KO to the applicable HCPCS drug code.
Modifier KO is primarily associated with Medicare DMEPOS claims for nebulizer medications used in the home. It identifies the formulation dispensed rather than the number of medications a beneficiary uses throughout the day.
Important: Modifier KO does not establish medical necessity or guarantee Medicare coverage. The medication and nebulizer treatment must meet the applicable coverage requirements.
Quick Reference
Modifier: KO
Meaning: Single Drug Unit Dose
Category: DMEPOS
Type: HCPCS Level II
Used For: Nebulizer Drugs
Billing: Formulation Modifier
When to Use Modifier KO
Single-Drug Unit-Dose Solutions
Report KO when one eligible inhalation drug is dispensed in a ready-to-use unit-dose container.
Nebulizer Medication Claims
Append KO to the applicable HCPCS unit-dose drug code when billing Medicare for qualifying nebulizer medications.
Ready-to-Use Formulations
Use KO when the dispensed medication is already diluted to the concentration required for nebulizer administration.
Individually Packaged Doses
KO applies to eligible single-drug inhalation solutions packaged in individual vials or ampules intended for one treatment.
Pharmacy-Prepared Unit Doses
When a concentrated single inhalation drug is diluted and dispensed in ready-to-use unit-dose containers, the resulting formulation is billed using the appropriate unit-dose code with KO, when applicable.
Important: Modifier selection depends on the formulation actually dispensed, not simply the original drug concentration or packaging purchased by the supplier.
When NOT to Use Modifier KO
Multiple-Drug Formulations
Do not report KO when two or more drugs are combined in the same unit-dose container. KP and KQ generally apply to the individual drug codes, subject to exceptions.
Concentrated Inhalation Solutions
Do not use KO with concentrated drug formulations requiring a separate diluent before administration.
FDA-Approved Combination Product J7620
Do not append KO to HCPCS J7620, which identifies the approved albuterol and ipratropium combination product.
Excluded Drug Codes
Medicare specifically excludes J2545 and Q4074 from KO reporting.
Nebulizer Equipment
KO identifies the medication formulation, not the nebulizer compressor, tubing, mask, or other equipment.
Non-Inhalation Drugs
Do not apply KO to unrelated injectable, oral, or topical medications merely because they are supplied in single-dose containers.
Modifier KO vs KP and KQ
These modifiers distinguish single-drug unit doses from multiple-drug formulations.
Modifier KO – Single Drug
Purpose: Identifies one drug in a unit-dose container.
When Used: An eligible single-drug nebulizer solution is dispensed ready to use.
Billing Focus: Single-drug formulation.
Modifier KP – First Drug
Purpose: Identifies one drug in a multiple-drug unit-dose formulation.
When Used: Two or more drugs are combined in the same unit-dose container.
Billing Focus: First reported drug component.
Modifier KQ – Additional Drug
Purpose: Identifies the other drug or drugs in a multiple-drug unit-dose formulation.
When Used: Additional drug components are billed separately under their respective unit-dose codes.
Billing Focus: Additional drug components.
Key Difference: KO identifies a single-drug formulation. KP and KQ identify individual components of a multiple-drug unit-dose formulation, except when specific billing rules require a combination-product code.
Billing Example
A Medicare beneficiary with chronic obstructive pulmonary disease (COPD) is prescribed albuterol inhalation solution for use with a home nebulizer.
The DMEPOS supplier dispenses 120 ready-to-use unit-dose vials containing only albuterol.
Example – Albuterol Unit-Dose Solution
HCPCS Code: J7613
Medication: Albuterol Inhalation Solution
Concentration: 0.083%
Vial Volume: 3 mL
Drug Amount: 2.5 mg per vial
Quantity Dispensed: 120 Vials
Billing Unit: 1 mg
Units Billed: 300
Modifier: KO
Example Claim: J7613-KO | 300 Units
Each vial contains 2.5 mg of albuterol. Multiplying 120 vials by 2.5 mg results in 300 HCPCS billing units.
Modifier KO identifies the medication as a single-drug unit-dose formulation.
Important: This calculation follows the example in Medicare's Nebulizers Policy Article. Coverage still depends on the prescription, medical necessity, and applicable DME MAC requirements.
Documentation Requirements
Documentation must support the prescribed medication, formulation dispensed, quantity supplied, and medical necessity for nebulizer therapy.
Standard Written Order
Maintain a valid order identifying the prescribed inhalation medication, dosage, frequency, and required information.
Drug Identification
Record the medication name, strength, concentration, and applicable HCPCS code.
Unit-Dose Packaging
Maintain records establishing that the drug was dispensed in ready-to-use unit-dose containers.
Quantity Dispensed
Document the number of vials or ampules supplied and the amount of medication contained in each.
Medical Necessity
Maintain clinical documentation supporting the beneficiary's respiratory condition and need for nebulizer medication.
Refill Documentation
For recurring supplies, maintain required refill requests and documentation supporting continued use.
Documentation Checklist
Valid standard written order
Medication and concentration verified
Single-drug formulation confirmed
Unit-dose packaging documented
HCPCS code verified
Billing units calculated
Medical necessity supported
Refill requirements satisfied
Medicare Nebulizer Drug Billing Rules
Required Unit-Dose Modifiers
Medicare requires KO, KP, or KQ on applicable unit-dose inhalation drug codes. Claims missing the required modifier are denied as invalid coding, subject to specified exceptions.
Single-Drug Formulations
KO identifies one drug dispensed in a unit-dose container. The medication must be ready for administration without adding a separate diluent.
Multiple-Drug Formulations
When two or more drugs are combined in the same unit-dose container, Medicare generally requires KP on one drug code and KQ on the additional drug codes.
Combination Product Exception
HCPCS J7620 identifies the FDA-approved combination of albuterol and ipratropium. KO, KP, and KQ must not be appended to this code.
Additional Code Exceptions
KO is not used with J2545 or Q4074, even though these codes may describe unit-dose medications.
Concentrated Formulations
KO, KP, and KQ are not used with concentrated inhalation drug codes. Suppliers must select the HCPCS code corresponding to the formulation actually dispensed.
Compounded Unit Doses
When a concentrated drug is diluted and dispensed as a ready-to-use unit dose, the supplier must use the appropriate unit-dose code. The diluent used to prepare the compounded unit dose is not billed separately.
HCPCS Billing Units
Billing units vary by drug code. Some codes are based on milligrams, while others represent a vial or specified dose. Suppliers must calculate units using the actual HCPCS descriptor.
Coverage Requirements
Medicare Part B coverage for nebulizer medications depends on the applicable DME benefit requirements, diagnosis, prescribed treatment, and medical necessity documentation.
Important: The presence of KO does not establish that the medication, quantity, or underlying respiratory condition meets Medicare coverage criteria.
Common Billing Errors & Denials
Omitting Required Modifier KO
Medicare specifically states that applicable unit-dose drug codes submitted without KO, KP, or KQ are denied as invalid coding, except for designated codes.
Using KO for Multiple-Drug Formulations
Reporting KO when two or more drugs are combined in the same unit-dose container misidentifies the formulation. KP and KQ generally apply instead.
Appending KO to J7620
Medicare prohibits KO, KP, and KQ on J7620 because the code already identifies the FDA-approved combination formulation.
Using KO With Excluded Codes
Appending KO to J2545 or Q4074 conflicts with Medicare's specific modifier exceptions.
Using KO With Concentrated Solutions
Concentrated inhalation medications requiring dilution must not be billed using KO. The appropriate concentrated-form HCPCS code should be reported.
Incorrect Drug Billing Units
Billing the number of vials instead of the HCPCS-defined drug quantity can result in incorrect reimbursement. For example, J7613 is billed per milligram rather than per vial.
Billing Diluent Separately
Separately reporting the diluent used to prepare a compounded unit-dose inhalation medication conflicts with Medicare's nebulizer drug billing instructions.
Insufficient Medical Necessity Documentation
An accurate modifier does not replace documentation supporting the medication, prescribed treatment, and applicable Medicare coverage requirements.
Frequently Asked Questions
Does Modifier KO apply when a beneficiary uses more than one nebulizer medication?
Yes. KO may still apply when a beneficiary uses multiple medications, provided the particular unit-dose container being billed contains only one drug. Modifier selection depends on the formulation dispensed, not the total number of medications prescribed.
Can Modifier KO be used for a single drug supplied in a multidose bottle?
No. KO identifies an eligible single-drug unit-dose formulation. A ready-to-use inhalation solution dispensed in a multidose container requires coding under the applicable multidose or other appropriate HCPCS code rather than KO.
ModifierLookup
Your trusted source for CPT and HCPCS modifier explanations, billing guidance, and coding resources
Categories
© 2025. All rights reserved.
Modifiers
Guides
Resources
Trusted Information
Practical Guidance
Accurate, up-to-date, and compliance-focused modifier guidance
Real-world billing examples and coding insights
Built for Professionals
Designed for coders, billers, and healthcare teams
Billing Guidelines
NCCI Edits Guide
Medicare Guidelines
Privacy Policy
Terms & Conditions
Sitemap
